MCKESSON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 559.9 USD | +0.86% |
|
+5.87% | +20.94% |
| 05-09 | Deutsche Bank Adjusts Price Target on McKesson to $545 From $547 | MT |
| 05-09 | Wells Fargo Adjusts Price Target on McKesson to $551 From $502 | MT |
| Sales 2025 * | 358B 28,576B | Sales 2026 * | 383B 30,582B | Capitalization | 72.78B 5,813B |
|---|---|---|---|---|---|
| Net income 2025 * | 3.72B 297B | Net income 2026 * | 3.9B 311B | EV / Sales 2025 * | 0.2 x |
| Net Debt 2025 * | 230M 18.33B | Net cash position 2026 * | 2.24B 179B | EV / Sales 2026 * | 0.18 x |
| P/E ratio 2025 * |
19.2
x | P/E ratio 2026 * |
17.8
x | Employees | 48,000 |
| Yield 2025 * |
0.49% | Yield 2026 * |
0.52% | Free-Float | 46.73% |
More Fundamentals
* Assessed data
More news
Latest transcript on McKesson Corporation
More recommendations
More press releases
More news
| 1 day | +0.86% | ||
| 1 week | +5.87% | ||
| Current month | +4.23% | ||
| 1 month | +5.65% | ||
| 3 months | +11.68% | ||
| 6 months | +19.31% | ||
| Current year | +20.94% |
1 week
530.80
566.01
1 month
514.88566.01
Current year
462.70566.01
1 year
373.28566.01
3 years
184.43566.01
5 years
112.60566.01
10 years
106.11566.01
| Managers | Title | Age | Since |
|---|---|---|---|
Brian Tyler
CEO | Chief Executive Officer | 57 | 31/12/11 |
| Director of Finance/CFO | 55 | 26/01/18 | |
Francisco Fraga
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Donald Knauss
CHM | Chairman | 73 | 19/10/14 |
Webster Dunbar
BRD | Director/Board Member | 62 | 31/03/22 |
| Director/Board Member | 66 | 12/01/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.31% | 0 M€ | +7.73% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 559.9 | +0.86% | 636,900 |
| 09/05/24 | 555.1 | +2.12% | 977,354 |
| 08/05/24 | 543.6 | -0.39% | 1,378,615 |
| 07/05/24 | 545.8 | +2.31% | 984,411 |
| 06/05/24 | 533.4 | +0.86% | 642,678 |
Delayed Quote Nyse, May 10, 2024 at 09:00 pm
More quotes
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
559.9
USD
Average target price
579.9
USD
Spread / Average Target
+3.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.94% | 72.78B | |
| -1.26% | 24.24B | |
| +8.25% | 8.38B | |
| +5.13% | 8.59B | |
| -19.42% | 8.09B | |
| +5.56% | 4.81B | |
| +16.83% | 4.32B | |
| -1.83% | 4.05B | |
| -1.65% | 3.93B | |
| +26.97% | 3.79B |
- Stock Market
- Equities
- MCK Stock
